Skip to content

In the BioHarmony Drug Report Database


Leqvio (inclisiran) is an oligonucleotide pharmaceutical. Inclisiran was first approved as Leqvio on 2020-12-09. It has been approved in Europe to treat dyslipidemias and hypercholesterolemia.
Trade Name Leqvio
Common Name Inclisiran
Indication dyslipidemias, hypercholesterolemia
Drug Class
Get full access now